ALNA - Allena Pharmaceutica...

Valuation of Allena Pharmaceuticals, Inc.(ALNA), Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes o

Allena Pharmaceuticals, Inc.

ALNA

NASDAQ

Inactive Equity

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

0.075 USD

0.0023000017 (3.07%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Sep 7, 2022 4:00 PM

Share Price on Valuation Date

$0.07

Stock Beta

1.149065

Shares Outstanding

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.